{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:36:36Z","timestamp":1789616196658,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH"},{"DOI":"10.13039\/100000928","name":"The Robert A. Welch Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Texas A&M University T3-Grants Program"},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04849-w","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:34:57Z","timestamp":1776782097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["FOXO1 in cancer: context-dependent roles, microRNA regulation, and therapeutic opportunities"],"prefix":"10.1007","volume":"17","author":[{"given":"Irene Chien Chien","family":"Ngu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiiben","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvester Yee Chun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Khoi","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammad","family":"Mufti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed F.","family":"Alshanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Fen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Yeng","family":"Looi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"4849_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115900","volume":"169","author":"M Ebrahimnezhad","year":"2023","unstructured":"Ebrahimnezhad M, Natami M, Bakhtiari GH, Tabnak P, Ebrahimnezhad N, Yousefi B, et al. FOXO1, a tiny protein with intricate interactions: promising therapeutic candidate in lung cancer. Biomed Pharmacother. 2023;169:115900. https:\/\/doi.org\/10.1016\/j.biopha.2023.115900.","journal-title":"Biomed Pharmacother"},{"key":"4849_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1101\/gad.14.2.142","volume":"14","author":"KH Kaestner","year":"2000","unstructured":"Kaestner KH, Knochel W, Martinez DE. Unified nomenclature for the winged helix\/forkhead transcription factors. Genes Dev. 2000;14:142\u20136. https:\/\/doi.org\/10.1101\/gad.14.2.142.","journal-title":"Genes Dev"},{"key":"4849_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0092-8674(90)90439-l","volume":"63","author":"D Weigel","year":"1990","unstructured":"Weigel D, J\u00e4ckle H. The fork head domain: a novel DNA binding motif of eukaryotic transcription factors? Cell. 1990;63:455\u20136. https:\/\/doi.org\/10.1016\/0092-8674(90)90439-l.","journal-title":"Cell"},{"key":"4849_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells8090966","volume":"8","author":"K Psenakova","year":"2019","unstructured":"Psenakova K, Kohoutova K, Obsilova V, Ausserlechner MJ, Veverka V, Obsil T. Forkhead domains of FOXO transcription factors differ in both overall conformation and dynamics. Cells. 2019;8:966. https:\/\/doi.org\/10.3390\/cells8090966.","journal-title":"Cells"},{"key":"4849_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7150\/ijbs.20052","volume":"13","author":"M Farhan","year":"2017","unstructured":"Farhan M, Wang H, Gaur U, Little PJ, Xu J, Zheng W. FOXO signaling pathways as therapeutic targets in cancer. Int J Biol Sci. 2017;13:815\u201327. https:\/\/doi.org\/10.7150\/ijbs.20052.","journal-title":"Int J Biol Sci"},{"key":"4849_CR6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","volume":"1813","author":"G Tzivion","year":"2011","unstructured":"Tzivion G, Dobson M, Ramakrishnan G. FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta BBA Mol Cell Res. 2011;1813:1938\u201345. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.06.002.","journal-title":"Biochim Biophys Acta BBA Mol Cell Res"},{"key":"4849_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118145","volume":"258","author":"B Zhang","year":"2020","unstructured":"Zhang B, Sun P, Shen C, Liu X, Sun J, Li D, et al. Role and mechanism of PI3K\/AKT\/FoxO1\/PDX-1 signaling pathway in functional changes of pancreatic islets in rats after severe burns. Life Sci. 2020;258:118145. https:\/\/doi.org\/10.1016\/j.lfs.2020.118145.","journal-title":"Life Sci"},{"key":"4849_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1750-2187-5-10","volume":"5","author":"SK Roy","year":"2010","unstructured":"Roy SK, Srivastava RK, Shankar S. Inhibition of PI3K\/AKT and MAPK\/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal. 2010;5:10. https:\/\/doi.org\/10.1186\/1750-2187-5-10.","journal-title":"J Mol Signal"},{"key":"4849_CR9","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1128\/MCB.01612-05","volume":"26","author":"P Bryant","year":"2006","unstructured":"Bryant P, Zheng Q, Pumiglia K. Focal adhesion kinase controls cellular levels of p27\/Kip1 and p21\/Cip1 through Skp2-dependent and -independent mechanisms. Mol Cell Biol. 2006;26:4201\u201313. https:\/\/doi.org\/10.1128\/MCB.01612-05.","journal-title":"Mol Cell Biol"},{"key":"4849_CR10","doi-asserted-by":"publisher","first-page":"C1238","DOI":"10.1152\/ajpcell.00349.2008","volume":"295","author":"SJ Lees","year":"2008","unstructured":"Lees SJ, Childs TE, Booth FW. Age-dependent FOXO regulation of p27Kip1 expression via a conserved binding motif in rat muscle precursor cells. Am J Physiol Cell Physiol. 2008;295:C1238\u201346. https:\/\/doi.org\/10.1152\/ajpcell.00349.2008.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4849_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4049\/jimmunol.2000216","volume":"206","author":"LB Hills","year":"2021","unstructured":"Hills LB, Abdullah L, Lust HE, Degefu H, Huang YH. Foxo1 serine 209 is a critical regulatory site of CD8 T cell differentiation and survival. J Immunol. 2021;206:89\u2013100. https:\/\/doi.org\/10.4049\/jimmunol.2000216.","journal-title":"J Immunol"},{"key":"4849_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1535-7163.MCT-13-0863","volume":"13","author":"KC Pramanik","year":"2014","unstructured":"Pramanik KC, Fofaria NM, Gupta P, Srivastava SK. CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT. Mol Cancer Ther. 2014;13:687\u201398. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0863.","journal-title":"Mol Cancer Ther"},{"key":"4849_CR13","doi-asserted-by":"publisher","first-page":"12096","DOI":"10.1074\/jbc.M412171200","volume":"280","author":"M Alikhani","year":"2005","unstructured":"Alikhani M, Alikhani Z, Graves DT. FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis. J Biol Chem. 2005;280:12096\u2013102. https:\/\/doi.org\/10.1074\/jbc.M412171200.","journal-title":"J Biol Chem"},{"key":"4849_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4161\/cc.4.1.1401","volume":"4","author":"H You","year":"2005","unstructured":"You H, Mak TW. Crosstalk between p53 and FOXO transcription factors. Cell Cycle. 2005;4:37\u20138. https:\/\/doi.org\/10.4161\/cc.4.1.1401.","journal-title":"Cell Cycle"},{"key":"4849_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/10715762.2022.2049770","volume":"56","author":"T Kamiya","year":"2022","unstructured":"Kamiya T, Yamaguchi Y, Oka M, Hara H. Combined action of FOXO1 and superoxide dismutase 3 promotes MDA-MB-231 cell migration. Free Radic Res. 2022;56:106\u201314. https:\/\/doi.org\/10.1080\/10715762.2022.2049770.","journal-title":"Free Radic Res"},{"key":"4849_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4315","volume":"5","author":"D Shao","year":"2014","unstructured":"Shao D, Zhai P, Del Re DP, Sciarretta S, Yabuta N, Nojima H, et al. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315. https:\/\/doi.org\/10.1038\/ncomms4315.","journal-title":"Nat Commun"},{"key":"4849_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ni.1612","volume":"9","author":"RH Amin","year":"2008","unstructured":"Amin RH, Schlissel MS. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol. 2008;9:613\u201322. https:\/\/doi.org\/10.1038\/ni.1612.","journal-title":"Nat Immunol"},{"key":"4849_CR18","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.2337\/db16-1600","volume":"66","author":"X Tong","year":"2017","unstructured":"Tong X, Zhang D, Charney N, Jin E, VanDommelen K, Stamper K, Gupta N, Saldate J, Yin L. DDB1-mediated CRY1 degradation promotes FOXO1-driven gluconeogenesis in liver. Diabetes. 2017;66:2571\u201382. https:\/\/doi.org\/10.2337\/db16-1600.","journal-title":"Diabetes"},{"key":"4849_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/gtc.12226","volume":"20","author":"T Arai","year":"2015","unstructured":"Arai T, Kano F, Murata M. Translocation of forkhead box O1 to the nuclear periphery induces histone modifications that regulate transcriptional repression of PCK1 in HepG2 cells. Genes Cells. 2015;20:340\u201357. https:\/\/doi.org\/10.1111\/gtc.12226.","journal-title":"Genes Cells"},{"key":"4849_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nature01667","volume":"423","author":"P Puigserver","year":"2003","unstructured":"Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 2003;423:550\u20135. https:\/\/doi.org\/10.1038\/nature01667.","journal-title":"Nature"},{"key":"4849_CR21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI12876","volume":"108","author":"J Nakae","year":"2001","unstructured":"Nakae J, Kitamura T, Silver DL, Accili D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest. 2001;108:1359\u201367. https:\/\/doi.org\/10.1172\/JCI12876.","journal-title":"J Clin Invest"},{"key":"4849_CR22","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-17-0002","volume":"233","author":"S Lee","year":"2017","unstructured":"Lee S, Dong HH. FoxO integration of insulin signaling with glucose and lipid metabolism. J Endocrinol. 2017;233:R67\u201379. https:\/\/doi.org\/10.1530\/JOE-17-0002.","journal-title":"J Endocrinol"},{"key":"4849_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8079","volume":"6","author":"I O-Sullivan","year":"2015","unstructured":"O-Sullivan I, Zhang W, Wasserman DH, Liew CW, Liu J, Paik J, et al. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nat Commun. 2015;6:7079. https:\/\/doi.org\/10.1038\/ncomms8079.","journal-title":"Nat Commun"},{"key":"4849_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.tcb.2008.07.004","volume":"18","author":"TB Dansen","year":"2008","unstructured":"Dansen TB, Burgering BMT. Unravelling the tumor-suppressive functions of FOXO proteins. Trends Cell Biol. 2008;18:421\u20139. https:\/\/doi.org\/10.1016\/j.tcb.2008.07.004.","journal-title":"Trends Cell Biol"},{"key":"4849_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000491670","volume":"48","author":"Z Gao","year":"2018","unstructured":"Gao Z, Liu R, Ye N, Liu C, Li X, Guo X, Zhang Z, Li X, Yao Y, Jiang X. FOXO1 inhibits tumor cell migration via regulating cell surface morphology in non-small cell lung cancer cells. Cell Physiol Biochem. 2018;48:138\u201348. https:\/\/doi.org\/10.1159\/000491670.","journal-title":"Cell Physiol Biochem"},{"key":"4849_CR26","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1182\/blood-2011-09-381905","volume":"119","author":"L Xie","year":"2012","unstructured":"Xie L, Ushmorov A, Leith\u00e4user F, Guan H, Steidl C, F\u00e4rbinger J, Pelzer C, Vogel MJ, Maier HJ, Gascoyne RD, M\u00f6ller P, Wirth T. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. Blood. 2012;119:3503\u201311. https:\/\/doi.org\/10.1182\/blood-2011-09-381905.","journal-title":"Blood"},{"key":"4849_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10092028","volume":"10","author":"BA Martin-Giacalone","year":"2021","unstructured":"Martin-Giacalone BA, Weinstein PA, Plon SE, Lupo PJ. Pediatric rhabdomyosarcoma: epidemiology and genetic susceptibility. J Clin Med. 2021;10:2028. https:\/\/doi.org\/10.3390\/jcm10092028.","journal-title":"J Clin Med"},{"key":"4849_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164034","volume":"15","author":"JT Wu","year":"2023","unstructured":"Wu JT, Cheuk A, Isanogle K, Robinson C, Zhang X, Ceribelli M, et al. Preclinical evaluation of the FGFR-family inhibitor futibatinib for pediatric rhabdomyosarcoma. Cancers. 2023;15:4034. https:\/\/doi.org\/10.3390\/cancers15164034.","journal-title":"Cancers"},{"key":"4849_CR29","doi-asserted-by":"publisher","first-page":"14242","DOI":"10.1038\/s41598-019-50592-4","volume":"9","author":"F Ghamloush","year":"2019","unstructured":"Ghamloush F, Ghayad SE, Rammal G, Fahs A, Ayoub AJ, Merabi Z, Harajly M, Zalzali H, Saab R. The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486. Sci Rep. 2019;9:14242. https:\/\/doi.org\/10.1038\/s41598-019-50592-4.","journal-title":"Sci Rep"},{"key":"4849_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.2","volume":"4","author":"JM Loupe","year":"2015","unstructured":"Loupe JM, Miller PJ, Ruffin DR, Stark MW, Hollenbach AD. Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options. Oncogenesis. 2015;4:e145. https:\/\/doi.org\/10.1038\/oncsis.2015.2.","journal-title":"Oncogenesis"},{"key":"4849_CR31","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s10147-019-01507-w","volume":"24","author":"DB Chay","year":"2019","unstructured":"Chay DB, Han GH, Nam S, Cho H, Chung J-Y, Hewitt SM. Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer. Int J Clin Oncol. 2019;24:1429\u201339. https:\/\/doi.org\/10.1007\/s10147-019-01507-w.","journal-title":"Int J Clin Oncol"},{"key":"4849_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1419072","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Jiang F, Zhu S, Jia H, Li C. STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC. Front Mol Biosci. 2024;11:1419072. https:\/\/doi.org\/10.3389\/fmolb.2024.1419072.","journal-title":"Front Mol Biosci"},{"key":"4849_CR33","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.celrep.2016.08.082","volume":"17","author":"AA Amit Mandoli, Singh","year":"2016","unstructured":"Amit Mandoli, Singh AA, Prange K, Tijchon E, Marjolein MP, Oerlemans, Ren\u00e9 AM, Dirks EM, Berentsen K, Sharifi N, Kim B, Matarese F, Nguyen LN, Hubner NC, Nagesha AS, Rao, Altucci L, Vellenga E, Stunnenberg HG, Joost HA, Martens. The hematopoietic transcription factors RUNX1 and ERG prevent AML1-ETO oncogene overexpression and onset of the apoptosis program in t(8;21) AMLs. Cell Rep. 2016;17:2087\u2013100. https:\/\/doi.org\/10.1016\/j.celrep.2016.08.082.","journal-title":"Cell Rep"},{"key":"4849_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1101\/2020.06.14.151159","volume":"81","author":"KR Stengel","year":"2020","unstructured":"Stengel KR, Ellis J, Spielman C, Bomber M, Hiebert SW. Definition of a small core transcriptional circuit regulated by AML1-ETO. Mol Cell. 2020;81:530. https:\/\/doi.org\/10.1101\/2020.06.14.151159.","journal-title":"Mol Cell"},{"key":"4849_CR35","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1038\/s41388-021-01952-w","volume":"40","author":"K Rejeski","year":"2021","unstructured":"Rejeski K, Duque-Afonso J, L\u00fcbbert M. AML1\/ETO and its function as a regulator of gene transcription via epigenetic mechanisms. Oncogene. 2021;40:5665\u201376. https:\/\/doi.org\/10.1038\/s41388-021-01952-w.","journal-title":"Oncogene"},{"key":"4849_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00480-z","volume":"13","author":"W Zhou","year":"2024","unstructured":"Zhou W, Li S, Wang H, Zhou J, Li S, Chen G, et al. A novel AML1-ETO\/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia. Exp Hematol Oncol. 2024;13:9. https:\/\/doi.org\/10.1186\/s40164-024-00480-z.","journal-title":"Exp Hematol Oncol"},{"key":"4849_CR37","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1182\/blood-2016-11-750976","volume":"130","author":"S Lin","year":"2017","unstructured":"Lin S, Ptasinska A, Chen X, Shrestha M, Assi SA, Chin PS, Imperato MR, Aronow BJ, Zhang J, Weirauch MT, Bonifer C, Mulloy JC. A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program. Blood. 2017;130:1213\u201322. https:\/\/doi.org\/10.1182\/blood-2016-11-750976.","journal-title":"Blood"},{"key":"4849_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.582915","author":"A Neaga","year":"2021","unstructured":"Neaga A, Bagacean C, Tempescul A, Jimbu L, Mesaros O, Blag C, et al. MicroRNAs associated with a good prognosis of acute myeloid leukemia and their effect on macrophage polarization. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2020.582915.","journal-title":"Front Immunol"},{"key":"4849_CR39","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","volume":"72","author":"J Bertacchini","year":"2015","unstructured":"Bertacchini J, Heidari N, Mediani L, Capitani S, Shahjahani M, Ahmadzadeh A, Saki N. Targeting PI3K\/AKT\/mTOR network for treatment of leukemia. Cell Mol Life Sci. 2015;72:2337\u201347. https:\/\/doi.org\/10.1007\/s00018-015-1867-5.","journal-title":"Cell Mol Life Sci"},{"key":"4849_CR40","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/ncb2293","volume":"13","author":"X Zhang","year":"2011","unstructured":"Zhang X, Yalcin S, Lee D-F, Yeh T-YJ, Lee S-M, Su J, Kumar MS, Rimmel\u00e9 P, Kennedy M, Sellers R, Landthaler M, Tuschl T, Chi N-W, Lemischka I, Keller G, Ghaffari S. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat Cell Biol. 2011;13:1092\u20139. https:\/\/doi.org\/10.1038\/ncb2293.","journal-title":"Nat Cell Biol"},{"key":"4849_CR41","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2174\/138945011796150325","volume":"12","author":"X Zhang","year":"2011","unstructured":"Zhang X, Rielland M, Yalcin S, Ghaffari S. Regulation and function of FoxO transcription factors in normal and cancer stem cells: what have we learned? Curr Drug Targets. 2011;12:1267\u201383. https:\/\/doi.org\/10.2174\/138945011796150325.","journal-title":"Curr Drug Targets"},{"key":"4849_CR42","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/ars.2010.3415","volume":"14","author":"MCW van den Berg","year":"2011","unstructured":"van den Berg MCW, Burgering BMT. Integrating opposing signals toward Forkhead box O. Antioxid Redox Signal. 2011;14:607\u201321. https:\/\/doi.org\/10.1089\/ars.2010.3415.","journal-title":"Antioxid Redox Signal"},{"key":"4849_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5619472","volume":"2017","author":"PM Aponte","year":"2017","unstructured":"Aponte PM, Caicedo A. Stemness in cancer: stem cells, cancer stem cells, and their microenvironment. Stem Cells Int. 2017;2017:1\u201317. https:\/\/doi.org\/10.1155\/2017\/5619472.","journal-title":"Stem Cells Int"},{"key":"4849_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.semcancer.2017.11.018","volume":"50","author":"S Yao","year":"2018","unstructured":"Yao S, Fan L-N, Lam E-F. The FOXO3-FOXM1 axis: a key cancer drug target and a modulator of cancer drug resistance. Semin Cancer Biol. 2018;50:77\u201389. https:\/\/doi.org\/10.1016\/j.semcancer.2017.11.018.","journal-title":"Semin Cancer Biol"},{"key":"4849_CR45","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","volume":"1813","author":"X Zhang","year":"2011","unstructured":"Zhang X, Tang N, Hadden TJ, Rishi AK. Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta. 2011;1813:1978\u201386. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.03.010.","journal-title":"Biochim Biophys Acta"},{"key":"4849_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-024-07242-1","volume":"629","author":"JD Chan","year":"2024","unstructured":"Chan JD, Scheffler CM, Munoz I, Sek K, Lee JN, Huang Y-K, et al. FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature. 2024;629:201\u201310. https:\/\/doi.org\/10.1038\/s41586-024-07242-1.","journal-title":"Nature"},{"key":"4849_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1174-3","volume":"38","author":"J Ling","year":"2019","unstructured":"Ling J, Wang F, Liu C, Dong X, Xue Y, Jia X, et al. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt\/\u03b2-catenin signaling. J Exp Clin Cancer Res. 2019;38:179. https:\/\/doi.org\/10.1186\/s13046-019-1174-3.","journal-title":"J Exp Clin Cancer Res"},{"key":"4849_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69338-8","volume":"10","author":"L Gheghiani","year":"2020","unstructured":"Gheghiani L, Shang S, Fu Z. Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer. Sci Rep. 2020;10:12327. https:\/\/doi.org\/10.1038\/s41598-020-69338-8.","journal-title":"Sci Rep"},{"key":"4849_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031469","volume":"25","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA. Trials and tribulations of microrna therapeutics. Int J Mol Sci. 2024;25:1469. https:\/\/doi.org\/10.3390\/ijms25031469.","journal-title":"Int J Mol Sci"},{"key":"4849_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol Lausanne. 2018. https:\/\/doi.org\/10.3389\/fendo.2018.00402.","journal-title":"Front Endocrinol Lausanne"},{"key":"4849_CR51","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/138920210793175895","volume":"11","author":"L-A MacFarlane","year":"2010","unstructured":"MacFarlane L-A, Murphy R. Microrna: biogenesis, function and role in cancer. Curr Genomics. 2010;11:537\u201361. https:\/\/doi.org\/10.2174\/138920210793175895.","journal-title":"Curr Genomics"},{"key":"4849_CR52","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201797943","volume":"37","author":"D Rajgor","year":"2018","unstructured":"Rajgor D, Sanderson TM, Amici M, Collingridge GL, Hanley JG. NMDAR-dependent Argonaute 2 phosphorylation regulates miRNA activity and dendritic spine plasticity. EMBO J. 2018;37:e97943. https:\/\/doi.org\/10.15252\/embj.201797943.","journal-title":"EMBO J"},{"key":"4849_CR53","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.devcel.2010.03.010","volume":"18","author":"N Liu","year":"2010","unstructured":"Liu N, Olson EN. Microrna regulatory networks in cardiovascular development. Dev Cell. 2010;18:510\u201325. https:\/\/doi.org\/10.1016\/j.devcel.2010.03.010.","journal-title":"Dev Cell"},{"key":"4849_CR54","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.coi.2011.02.001","volume":"23","author":"L Belver","year":"2011","unstructured":"Belver L, Papavasiliou FN, Ramiro AR. Microrna control of lymphocyte differentiation and function. Curr Opin Immunol. 2011;23:368\u201373. https:\/\/doi.org\/10.1016\/j.coi.2011.02.001.","journal-title":"Curr Opin Immunol"},{"key":"4849_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bav102","volume":"2015","author":"Z-W Guo","year":"2015","unstructured":"Guo Z-W, Xie C, Yang J-R, Li J-H, Yang J-H, Zheng L. MtiBase: a database for decoding microRNA target sites located within CDS and 5\u2032UTR regions from CLIP-Seq and expression profile datasets. Database. 2015;2015:bav102. https:\/\/doi.org\/10.1093\/database\/bav102.","journal-title":"Database"},{"key":"4849_CR56","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nbt.3947","volume":"35","author":"D de Rie","year":"2017","unstructured":"de Rie D, Abugessaisa I, Alam T, Arner E, Arner P, Ashoor H, et al. An integrated expression atlas of miRNAs and their promoters in human and mouse. Nat Biotechnol. 2017;35:872\u20138. https:\/\/doi.org\/10.1038\/nbt.3947.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"4849_CR57","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.mce.2015.01.035","volume":"418","author":"CM Klinge","year":"2015","unstructured":"Klinge CM. MiRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cell Endocrinol. 2015;418(3):273\u201397. https:\/\/doi.org\/10.1016\/j.mce.2015.01.035.","journal-title":"Mol Cell Endocrinol"},{"key":"4849_CR58","doi-asserted-by":"publisher","first-page":"11502","DOI":"10.3390\/ijms231911502","volume":"23","author":"A Menon","year":"2022","unstructured":"Menon A, Abd-Aziz N, Khalid K, Poh CL, Naidu R. MiRNA: a promising therapeutic target in cancer. Int J Mol Sci. 2022;23:11502. https:\/\/doi.org\/10.3390\/ijms231911502.","journal-title":"Int J Mol Sci"},{"key":"4849_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-pharmtox-010510-100517","volume":"51","author":"M Garofalo","year":"2011","unstructured":"Garofalo M, Croce CM. MicroRNAs: master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol. 2011;51:25\u201343. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010510-100517.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4849_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.708765","author":"K Otmani","year":"2021","unstructured":"Otmani K, Lewalle P. Tumor suppressor miRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.708765.","journal-title":"Front Oncol"},{"key":"4849_CR61","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS, Kang Y-K, Borad M, Sachdev J, Ejadi S, Lim HY, Brenner AJ, Park K, Lee J-L, Kim T-Y, Shin S, Becerra CR, Falchook G, Stoudemire J, Martin D, Kelnar K, Peltier H, Bonato V, Bader AG, Smith S, Kim S, O\u2019Neill V, Beg MS. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020;122:1630\u20137. https:\/\/doi.org\/10.1038\/s41416-020-0802-1.","journal-title":"Br J Cancer"},{"key":"4849_CR62","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","volume":"35","author":"MS Beg","year":"2016","unstructured":"Beg MS, Brenner AJ, Sachdev J, Borad M, Kang Y-K, Stoudemire J, Smith S, Bader AG, Kim S, Hong DS. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest New Drugs. 2016;35:180\u20138. https:\/\/doi.org\/10.1007\/s10637-016-0407-y.","journal-title":"Invest New Drugs"},{"key":"4849_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2017.10.010","volume":"361","author":"L-J Li","year":"2017","unstructured":"Li L-J, Leng R-X, Fan Y-G, Pan H-F, Ye D-Q. Translation of noncoding RNAs: focus on lncRNAs, pri-miRNAs, and circRNAs. Exp Cell Res. 2017;361:1\u20138. https:\/\/doi.org\/10.1016\/j.yexcr.2017.10.010.","journal-title":"Exp Cell Res"},{"key":"4849_CR64","first-page":"1146","volume":"13","author":"C-Y Liang","year":"2020","unstructured":"Liang C-Y, Huang Z-G, Tang Z-Q, Xiao X-L, Zeng J-J, Feng Z-B. FOXO1 and hsa-microRNA-204-5p affect the biologic behavior of MDA-MB-231 breast cancer cells. Int J Clin Exp Pathol. 2020;13:1146\u201358.","journal-title":"Int J Clin Exp Pathol"},{"key":"4849_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10423-8","author":"A Kar","year":"2022","unstructured":"Kar A, Kumari K, Mishra SK, Subudhi U. Self-assembled DNA nanostructure containing oncogenic miRNA-mediated cell proliferation by downregulation of FOXO1 expression. BMC Cancer. 2022. https:\/\/doi.org\/10.1186\/s12885-022-10423-8.","journal-title":"BMC Cancer"},{"key":"4849_CR66","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.febslet.2012.02.050","volume":"586","author":"L Wu","year":"2012","unstructured":"Wu L, Li H, Jia CY, Cheng W, Yu M, Peng M, Zhu Y, Zhao Q, Dong YW, Shao K, Wu A, Wu XZ. MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett. 2012;586:1038\u201343. https:\/\/doi.org\/10.1016\/j.febslet.2012.02.050.","journal-title":"FEBS Lett"},{"key":"4849_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9966744","volume":"2021","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhang J, Yang W, Yang Z, Zhou K. MicroRNA-552 accelerates the progression of gastric cancer by targeting FOXO1 and regulating PI3K\/AKT pathway. J Oncol. 2021;2021:1\u20139. https:\/\/doi.org\/10.1155\/2021\/9966744.","journal-title":"J Oncol"},{"key":"4849_CR68","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/bjc.2013.829","volume":"110","author":"T Hou","year":"2014","unstructured":"Hou T, Ou J, Zhao X, Huang X, Huang Y, Zhang Y. MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1. Br J Cancer. 2014;110:1260\u20138. https:\/\/doi.org\/10.1038\/bjc.2013.829.","journal-title":"Br J Cancer"},{"key":"4849_CR69","first-page":"10294","volume":"8","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zhao S, Cui M, Wang Q. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1. Int J Clin Exp Pathol. 2015;8:10294.","journal-title":"Int J Clin Exp Pathol"},{"key":"4849_CR70","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.3892\/or.2017.5873","volume":"38","author":"L Yang","year":"2017","unstructured":"Yang L, Peng F, Qin J, Zhou H, Wang B. Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1. Oncol Rep. 2017;38:2148\u201354. https:\/\/doi.org\/10.3892\/or.2017.5873.","journal-title":"Oncol Rep"},{"key":"4849_CR71","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3233\/cbm-201685","volume":"29","author":"L Zhu","year":"2020","unstructured":"Zhu L, Chen Y, Liu J, Nie K, Xiao Y, Yu H. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K\/AKT pathway. Cancer Biomark. 2020;29:347\u201357. https:\/\/doi.org\/10.3233\/cbm-201685.","journal-title":"Cancer Biomark"},{"key":"4849_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045825","volume":"7","author":"Z Wu","year":"2012","unstructured":"Wu Z, Sun H, Zeng W, He J, Mao X. Upregulation of mircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS One. 2012;7:e45825. https:\/\/doi.org\/10.1371\/journal.pone.0045825.","journal-title":"PLoS One"},{"key":"4849_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0865-y","author":"J Wang","year":"2017","unstructured":"Wang J, Song C, Tang H, Zhang C, Tang J, Li X, et al. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer. Breast Cancer Res. 2017. https:\/\/doi.org\/10.1186\/s13058-017-0865-y.","journal-title":"Breast Cancer Res"},{"key":"4849_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11309","author":"M Zhao","year":"2016","unstructured":"Zhao M, Luo R, Liu Y, Gao L, Fu Z, Fu Q, et al. miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR\u2013p-PI3K\/AKT-c-JUN. Nat Commun. 2016. https:\/\/doi.org\/10.1038\/ncomms11309.","journal-title":"Nat Commun"},{"key":"4849_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01362","author":"C Wang","year":"2018","unstructured":"Wang C, Liu E, Li W, Cui J, Li T. MiR-3188 inhibits non-small cell lung cancer cell proliferation through FOXO1-mediated mTOR-p-PI3K\/AKT-c-JUN signaling pathway. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.01362.","journal-title":"Front Pharmacol"},{"key":"4849_CR76","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mcp.2019.02.001","volume":"44","author":"H Liu","year":"2019","unstructured":"Liu H, Ni Z, Shi L, Ma L, Zhao J. MiR-486-5p inhibits the proliferation of leukemia cells and induces apoptosis through targeting FOXO1. Mol Cell Probes. 2019;44:37\u201343. https:\/\/doi.org\/10.1016\/j.mcp.2019.02.001.","journal-title":"Mol Cell Probes"},{"key":"4849_CR77","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/path.4030","volume":"227","author":"J Xia","year":"2012","unstructured":"Xia J, Wu Z, Yu C, He W, Zheng H, He Y, Jian W, Chen L, Zhang L, Li W. miR-124 inhibits cell proliferation in gastric cancer through down\u2010regulation of SPHK1. J Pathol. 2012;227:470\u201380. https:\/\/doi.org\/10.1002\/path.4030.","journal-title":"J Pathol"},{"key":"4849_CR78","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s13273-018-0009-1","volume":"14","author":"Y Li","year":"2018","unstructured":"Li Y, Wu Y. MiR-200-3p inhibits tumor cell proliferation and induces apoptosis by upregulation of FOXO1 in osteosarcoma cells. Mol Cell Toxicol. 2018;14:73\u20138. https:\/\/doi.org\/10.1007\/s13273-018-0009-1.","journal-title":"Mol Cell Toxicol"},{"key":"4849_CR79","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-761728\/v1","author":"H Hu","year":"2021","unstructured":"Hu H, Huang W, Li J, Zhang Q, Miao Y-R, Hu F-F, Gan L, Yang X, Guo A-Y. A miR-9-5p\/FOXO1\/CPEB3 feed-forward loop drives the progression of hepatocellular carcinoma. Res Sq Res Sq. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-761728\/v1.","journal-title":"Res Sq Res Sq"},{"key":"4849_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07324-z","author":"W Gao","year":"2020","unstructured":"Gao W, Liang J, Ye Y, Lu J, Lin T, Wang N, et al. FUT4siRNA augments the chemosensitivity of non-small cell lung cancer to cisplatin through activation of FOXO1-induced apoptosis. BMC Cancer. 2020. https:\/\/doi.org\/10.1186\/s12885-020-07324-z.","journal-title":"BMC Cancer"},{"key":"4849_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10423-8","author":"A Kar","year":"2022","unstructured":"Kar A, Kumari K, Mishra SK, Subudhi U. Self-assembled DNA nanostructure containing oncogenic miRNA-mediated cell proliferation by downregulation of FOXO1 expression. BMC Cancer. 2022. https:\/\/doi.org\/10.1186\/s12885-022-10423-8.","journal-title":"BMC Cancer"},{"key":"4849_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071852","author":"A Forterre","year":"2020","unstructured":"Forterre A, Komuro H, Aminova S, Harada M. A comprehensive review of cancer microRNA therapeutic delivery strategies. Cancers. 2020. https:\/\/doi.org\/10.3390\/cancers12071852.","journal-title":"Cancers"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04849-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04849-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04849-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:04:25Z","timestamp":1780625065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04849-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4849"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04849-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"853"}}